Rheumatoid Arthritis News

The prevalence of poor prognostic factors among patients with rheumatoid arthritis — such as functional limitation, extra-articular disease, seropositivity and erosions — does not predict the use of biologic or targeted synthetic disease modifying antirheumatic drugs, according to findings published in the Journal of Rheumatology.

Approximately 36% of patients with early rheumatoid arthritis disagree with their physician regarding whether they are in remission, according to findings published in BMC Rheumatology.

Physicians generally prescribe different initial treatments for men and women with rheumatoid arthritis, suggesting a slightly less aggressive approach for women compared with men, according to findings published in the Journal of Rheumatology.

Healio Rheumatology is proud to announce the launch of Rheuminations, a podcast series hosted by Adam Brown, MD, focusing on medical mysteries and other ripping yarns of the immune system gone awry.

Vulnerable patients with rheumatoid arthritis experience difficulty with the patient global assessment of disease activity as measured by visual analogue scale, with about 40% finding it confusing, according to findings published in Arthritis Care & Research.

Treatment with androgen deprivation therapy appeared to increase risk for rheumatoid arthritis among older men with localized prostate cancer, according to study results.

Health-related quality of life measures for patients with rheumatoid arthritis and psoriatic arthritis were generally similar, with a tendency toward worse scores among those with psoriatic arthritis, according to findings published in the Annals of the Rheumatic Diseases.

Patients with rheumatoid arthritis have a substantially greater risk for glucocorticoid-related adverse effects compared with their healthy peers, and increasing cumulative and average daily doses were associated with an increased risk for adverse effects, according to findings published in Arthritis Care & Research.

AMSTERDAM — Multicenter registries and multidisciplinary approaches are needed to better understand the risks for infection associated with individual drugs used to treat rheumatoid arthritis, according to a presenter at the EULAR Annual Congress.

AMSTERDAM — There is no evidence that treatment with glucocorticoid affects clinical efficacy or safety when concomitantly administered with tocilizumab, methotrexate or adalimumab, according to a post-hoc analysis of four randomized, controlled trials presented at the EULAR Annual Congress.